Certified Urologist, Data scientist. Korea(South)
Assistant Professor, Department of Urology, Asan Medical Center.
Privacy Enhancing Technology Evangelist.
A Critical Look at the Issue of Causal Inference
@DeatonAngus and Nancy Cartwright raise doubts about the view that randomized controlled trials (RCTs) should be assigned a special status. See https://t.co/YTdgsI8ER8
For a response by @guido_imbens, see: https://t.co/9oRJpGn9NW
Thank you for sharing our study. I cannot share the actual prompt due to safety issue, but I can share demonstration video of "client side injection" using chrome browser extension.
#indirectpromptinjection#AIsafety#LLM
You can get ChatGPT to recommend thalidomide to a pregnant woman.
It's not even hard.
A new study in JAMA Network Open shows just how vulnerable medical AI is to manipulation. 🧵
@ballingt Here's a demo of the client-side injection in action:
I can see how Phase 1 might look like jailbreaking from the paper alone. Fair point, and appreciate the discussion. Always open to feedback on terminology :)
@ballingt Hi! Paper author here. We prepend fake [SYSTEM] tags to user queries with fabricated medical evidence (fake trials, fake FDA EUA). To make the model interprets it as system-level instructions. That's why we went with "prompt injection."
New paper in Radiology:AI - privacy-preserving deep learning using HE for kidney CT classification.
12,446 images, AUC 0.89-0.99, no performance loss. Data stays encrypted during inference.
https://t.co/1vbIUFKfac
@heaan_AI@AsanMedicalCtr@Radiology_AI
World Medical Association Clarifies Position on Collective Action and Condemns Government Interference in Korean Medical Association.
Full Press Release: https://t.co/Nbu1iuUNPI
#SupportKMA@kmasns#korea
Erectile Dysfunction in a Sample of Sexually Active Young Adult Men from a U.S. Cohort: Demographic, Metabolic and Mental Health Correlates https://t.co/7TztRiINUX
A decision-supporting tool using Explainable AI was developed and validated for calculating the probability of prostate cancer prior to prostate biopsy. https://t.co/ljfCz04Rj4 @BJUIjournal#ArtificialIntelligence#MachineLearning
@TharaniNitkunan@Issarami This is what we proposed as escalate down activity @GuysUrology - What stage really depends on what reduction the hospital ask is asking for - but does help to keep treating patients who most need it. Assumes bed, theatre and anaesthetist availability. HT: @benchallacombe
Germline DNA copy number polymorphism to predict the efficacy of BCG therapy for non-muscle invasive #BladderCancer. Presentation by Yoshiaki Yamamoto, MD. Coverage by @zklaassen_md@GACancerCenter on UroToday > https://t.co/3jAknCWPDo @ASCO#GU20